Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
出版年份 2015 全文链接
标题
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 7, Pages e0133488
出版商
Public Library of Science (PLoS)
发表日期
2015-08-01
DOI
10.1371/journal.pone.0133488
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RETRACTED: Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma
- (2014) Jonggi Choi et al. JOURNAL OF HEPATOLOGY
- EASL and mRECIST responses are independent predictors of survival in hepatocellular carcinoma patients treated with cryoablation
- (2013) Huzi Li et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Assessment of treatment response in hepatocellular carcinoma: a review of the literature
- (2013) Marcello Maida et al. Future Oncology
- Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
- (2013) Eun Suk Jung et al. JOURNAL OF HEPATOLOGY
- Response Evaluation Criteria in Solid Tumors (RECIST) Criteria Are Superior to European Association for Study of the Liver (EASL) Criteria at 1 Month Follow-up for Predicting Long-term Survival in Patients Treated with Transarterial Chemoembolization before Liver Transplantation for Hepatocellular Cancer
- (2013) Anatoly Shuster et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma
- (2013) Chang Joon Kim et al. LIVER INTERNATIONAL
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Assessment of Liver Tumor Response to Therapy: Role of Quantitative Imaging
- (2013) Fernanda D. Gonzalez-Guindalini et al. RADIOGRAPHICS
- mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
- (2012) H. J. Prajapati et al. ANNALS OF ONCOLOGY
- Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
- (2012) Beom Kyung Kim et al. EUROPEAN JOURNAL OF CANCER
- Quantitative and Volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors Measurements: Feasibility of a Semiautomated Software Method to Assess Tumor Response after Transcatheter Arterial Chemoembolization
- (2012) MingDe Lin et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
- (2012) Yozo Sato et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma
- (2011) Tracy R. Price et al. CANCER
- Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
- (2011) Judith Meza-Junco et al. CANCER TREATMENT REVIEWS
- EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
- (2011) Roopinder Gillmore et al. JOURNAL OF HEPATOLOGY
- Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models
- (2011) Ju Hyun Shim et al. RADIOLOGY
- Imaging Response in the Primary Index Lesion and Clinical Outcomes Following Transarterial Locoregional Therapy for Hepatocellular Carcinoma
- (2010) Ahsun Riaz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Agreement between Competing Imaging Measures of Response of Hepatocellular Carcinoma to Yttrium-90 Radioembolization
- (2010) Eugene Duke et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and Resection
- (2008) Dario Ribero et al. ANNALS OF SURGICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search